Join to View Full Profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Are you Dr. Hess?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Hess, MD is an oncologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina, Missouri, and Illinois.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2013 - 2016
Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
University of Missouri-Columbia School of MedicineClass of 2010
Certifications & Licensure
SC State Medical License 2016 - 2025
MO State Medical License 2013 - 2017
IL State Medical License 2010 - 2014- IL State Medical License 2010 - 2014
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 study.Mehdi Hamadani, Paolo F Caimi, Brian Hess, John Radford, Melhem Solh
Future Oncology. 2025-02-01 - Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.Kelly J Gaffney, Jonathan K Bakos, Arash Velayati, James A Davis, Aswani Thurlapati
Journal of Oncology Pharmacy Practice. 2025-01-01 - 14 citationsNivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.Alex F Herrera, Michael LeBlanc, Sharon M Castellino, Hongli Li, Sarah C Rutherford
The New England Journal of Medicine. 2024-10-17
Press Mentions
Medical Student Carries Her Lymphoma Experience with HerMarch 15th, 2023- Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab Protects Blood Cancer Patients Against COVIDDecember 16th, 2022
- Oncologist Leaves a Lasting Legacy at MUSC Hollings Cancer CenterJune 23rd, 2021
Grant Support
- Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLLMEDICAL UNIVERSITY OF SOUTH CAROLINA2024–2029
- A Pilot Clinical Study for a Novel Bioresorbable Bone Adhesive to Evidence Improved Cranial Flap Fixation Based on Radiographic Imaging and Patient Reported OutcomesREVBIO, INC.2024–2026
- A Pilot Clinical Study for a Novel Bioresorbable Bone Adhesive to Evidence Improved Cranial Flap Fixation Based on Radiographic Imaging and Patient Reported OutcomesREVBIO, INC.2024–2026
- Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging PatientsREVBIO, INC.2023–2026
- Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging PatientsREVBIO, INC.2023–2026
